SPIA
COYA icon

Steward Partners Investment Advisory’s Coya Therapeutics COYA Stock Holding History

Steward Partners Investment Advisory’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.97K Hold
500
– – ﹤0.01% 4059
2025
Q4 		$2.9K Hold
500
– – ﹤0.01% 3860
2025
Q3 		$2.85K Hold
500
– – ﹤0.01% 3820
2025
Q2 		$2.88K Hold
500
– – ﹤0.01% 3655
2025
Q1 		$3.23K Hold
500
– – ﹤0.01% 3513
2024
Q4 		$2.87K Buy
+500
New +$3.41K ﹤0.01% 3540

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Steward Partners Investment Advisory's COYA Position: Q1 2026 in Review

Steward Partners Investment Advisory held its Coya Therapeutics (COYA) position steady in Q1 2026 at 500 shares worth $1.97K. The position accounts for ﹤0.01% of the portfolio, ranked #4059.

Steward Partners Investment Advisory first reported a position in COYA in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.23K in Q1 2025. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Steward Partners Investment Advisory held 500 shares of Coya Therapeutics worth $1.97K as of Q1 2026.
  • Steward Partners Investment Advisory left its Coya Therapeutics share count unchanged in Q1 2026.
  • Coya Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #4059 holding.
  • Steward Partners Investment Advisory first reported a position in Coya Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Steward Partners Investment Advisory's Coya Therapeutics position peaked at $3.23K in Q1 2025.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.